IBDEI11C ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16829,1,3,0)
 ;;=3^Tuberculosis of Lung
 ;;^UTILITY(U,$J,358.3,16829,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,16829,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,16830,0)
 ;;=B20.^^61^777^34
 ;;^UTILITY(U,$J,358.3,16830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16830,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,16830,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,16830,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,16831,0)
 ;;=B02.9^^61^777^100
 ;;^UTILITY(U,$J,358.3,16831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16831,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,16831,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,16831,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,16832,0)
 ;;=A60.9^^61^777^2
 ;;^UTILITY(U,$J,358.3,16832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16832,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,16832,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,16832,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,16833,0)
 ;;=A60.04^^61^777^37
 ;;^UTILITY(U,$J,358.3,16833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16833,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,16833,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,16833,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,16834,0)
 ;;=A60.01^^61^777^35
 ;;^UTILITY(U,$J,358.3,16834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16834,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,16834,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,16834,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,16835,0)
 ;;=B00.1^^61^777^36
 ;;^UTILITY(U,$J,358.3,16835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16835,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,16835,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,16835,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,16836,0)
 ;;=B97.89^^61^777^96
 ;;^UTILITY(U,$J,358.3,16836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16836,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,16836,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,16836,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,16837,0)
 ;;=B97.10^^61^777^24
 ;;^UTILITY(U,$J,358.3,16837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16837,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,16837,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,16837,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,16838,0)
 ;;=B34.9^^61^777^97
 ;;^UTILITY(U,$J,358.3,16838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16838,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,16838,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,16838,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,16839,0)
 ;;=A69.20^^61^777^53
 ;;^UTILITY(U,$J,358.3,16839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16839,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16839,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,16839,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,16840,0)
 ;;=A69.22^^61^777^55
 ;;^UTILITY(U,$J,358.3,16840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16840,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,16840,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,16840,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,16841,0)
 ;;=A69.21^^61^777^54
 ;;^UTILITY(U,$J,358.3,16841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16841,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,16841,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,16841,2)
 ;;=^5000376
